Tristel plc (TSNLF)

Market Cap	257.36M +9.3%
Revenue (ttm)	66.67M +13.7%
Net Income	10.58M +28.1%
EPS	0.22 +26.1%
Shares Out	n/a
PE Ratio	24.32
Forward PE	20.74
Dividend	n/a
Ex-Dividend Date	n/a

Volume	400
Open	6.00
Previous Close	5.74
Day's Range	5.74 - 6.00
52-Week Range	5.00 - 6.00
Beta	0.34
Analysts	n/a
Price Target	n/a
Est. Earnings	Oct 12, 2026

About Tristel

Tristel plc develops, manufactures, and sells infection prevention products in the United Kingdom, Australia, Germany, Western Europe, and internationally. The company operates through three segments: Hospital Medical Device Decontamination, Hospital Environmental Surface Disinfection, and Other. It offers device decontamination products, including wipes system, ULT, OPH, Stella system, fuse for Stella, rinse assure, clean, EVE, medistel, EVA system, daisygrip, fuse for surfaces, dosing system, airstel, enzystel, DOK, pre-clean wipes, rinse wip...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1993
• Employees: 270
• Stock Exchange: OTCMKTS
• Ticker Symbol: TSNLF

Financial Performance

In fiscal year 2025, Tristel's revenue was 46.46 million, an increase of 10.80% compared to the previous year's 41.93 million. Earnings were 6.64 million, an increase of 2.33%.

Financial numbers in GBP

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Sep 25, 2026

Data Sources Report a data error